Literature DB >> 22612792

Elevated circulating tissue factor procoagulant activity, factor VII, and plasminogen activator inhibitor-1 in childhood obesity: evidence of a procoagulant state.

Anamika Singh1, Gary D Foster, Jay Gunawardana, Tara Alexis McCoy, Tina Nguyen, Stephanie Vander Veur, Eugene Komaroff, Angara Koneti Rao.   

Abstract

Childhood obesity is rapidly increasing in prevalence. We compared circulating membrane-bound tissue factor (FIII, F3) procoagulant activity (TF-PCA) and plasma markers of coagulation, fibrinolysis and endothelial dysfunction in 21 obese (10·1 ± 1·5 years, mean ± standard deviation) and 22 healthy weight children (9·9 ± 1·6 years), classified by Body Mass Index (BMI). TF-PCA and factor VII coagulant activity (FVII:C), plasminogen activator inhibitor (PAI-1, SERPINE1) and soluble vascular cell adhesion molecule 1 (sVCAM1) were higher in obese children. BMI correlated positively with TF-PCA, FVII:C, and PAI-1. Childhood obesity is associated with a procoagulant state and endothelial dysfunction. Studies are needed to assess whether weight reduction reverses these abnormalities.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22612792      PMCID: PMC3406232          DOI: 10.1111/j.1365-2141.2012.09160.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  14 in total

1.  Tissue factor and obesity, a two-way street.

Authors:  Nan Zhang; Daniel A Lawrence
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

2.  Effects of hyperglycemia and hyperinsulinemia on circulating tissue factor procoagulant activity and platelet CD40 ligand.

Authors:  Vijender R Vaidyula; A Koneti Rao; Maria Mozzoli; Carol Homko; Peter Cheung; Guenther Boden
Journal:  Diabetes       Date:  2006-01       Impact factor: 9.461

3.  Plasminogen activator inhibitor-1 promotes formation of endothelial microparticles with procoagulant potential.

Authors:  Sergey V Brodsky; Kazimierz Malinowski; Marc Golightly; Jolyon Jesty; Michael S Goligorsky
Journal:  Circulation       Date:  2002-10-29       Impact factor: 29.690

4.  Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease.

Authors:  N S Key; A Slungaard; L Dandelet; S C Nelson; C Moertel; L A Styles; F A Kuypers; R R Bach
Journal:  Blood       Date:  1998-06-01       Impact factor: 22.113

5.  Interrelationship between estimates of adiposity and body fat distribution with metabolic and hemostatic parameters in obese children.

Authors:  K Sudi; S Gallistl; D Payerl; R Aigner; R Möller; E Tafeit; M H Borkenstein
Journal:  Metabolism       Date:  2001-06       Impact factor: 8.694

6.  Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity.

Authors:  Antonia Sambola; Julio Osende; James Hathcock; Michael Degen; Yale Nemerson; Valentin Fuster; Jill Crandall; Juan Jose Badimon
Journal:  Circulation       Date:  2003-02-25       Impact factor: 29.690

Review 7.  Obesity, haemostasis and the fibrinolytic system.

Authors:  I Mertens; L F Van Gaal
Journal:  Obes Rev       Date:  2002-05       Impact factor: 9.213

8.  Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus.

Authors:  James B Meigs; Frank B Hu; Nader Rifai; JoAnn E Manson
Journal:  JAMA       Date:  2004-04-28       Impact factor: 56.272

Review 9.  Tissue factor in hemostasis and thrombosis.

Authors:  Rachel Tilley; Nigel Mackman
Journal:  Semin Thromb Hemost       Date:  2006-02       Impact factor: 4.180

10.  Tissue factor-protease-activated receptor 2 signaling promotes diet-induced obesity and adipose inflammation.

Authors:  Leylla Badeanlou; Christian Furlan-Freguia; Guang Yang; Wolfram Ruf; Fahumiya Samad
Journal:  Nat Med       Date:  2011-10-23       Impact factor: 53.440

View more
  8 in total

1.  Obesity is associated with postinjury hypercoagulability.

Authors:  Jason M Samuels; Ernest E Moore; Julia R Coleman; Joshua J Sumislawski; Mitchell J Cohen; Christopher C Silliman; Anirban Banerjee; Arsen Ghasabyan; James Chandler; Angela Sauaia
Journal:  J Trauma Acute Care Surg       Date:  2019-10       Impact factor: 3.313

Review 2.  Adipokines: a link between obesity and dementia?

Authors:  Amanda J Kiliaan; Ilse A C Arnoldussen; Deborah R Gustafson
Journal:  Lancet Neurol       Date:  2014-09       Impact factor: 44.182

3.  Portal vein thrombosis after laparoscopic splenectomy during childhood.

Authors:  Thomas Gelas; Aurélien Scalabre; Frédéric Hameury; Rémi Dubois; Céline Grosos; Pierre D Mouriquand; Pierre-Yves Mure
Journal:  J Thromb Thrombolysis       Date:  2014       Impact factor: 2.300

Review 4.  Mechanisms of thrombosis in obesity.

Authors:  Ilya O Blokhin; Steven R Lentz
Journal:  Curr Opin Hematol       Date:  2013-09       Impact factor: 3.284

Review 5.  Obesity and dementia: adipokines interact with the brain.

Authors:  Ilse A C Arnoldussen; Amanda J Kiliaan; Deborah R Gustafson
Journal:  Eur Neuropsychopharmacol       Date:  2014-03-20       Impact factor: 4.600

Review 6.  Obesity: physiologic changes and implications for preoperative management.

Authors:  Vilma E Ortiz; Jean Kwo
Journal:  BMC Anesthesiol       Date:  2015-07-04       Impact factor: 2.217

7.  Age- and BMI-Associated Expression of Angiogenic Factors in White Adipose Tissue of Children.

Authors:  Niklas Gaebler; Benedikt Haggenmüller; Melanie Kapapa; Alexandre Serra; Daniel Tews; Jan-Bernd Funcke; Stephanie Brandt; Valentin Ioannidis; Michael Schön; Peter Möller; Klaus-Michael Debatin; Martin Wabitsch; Pamela Fischer-Posovszky
Journal:  Int J Mol Sci       Date:  2019-10-21       Impact factor: 5.923

8.  Mendelian Randomisation study of the influence of eGFR on coronary heart disease.

Authors:  Pimphen Charoen; Dorothea Nitsch; Jorgen Engmann; Tina Shah; Jonathan White; Delilah Zabaneh; Barbara Jefferis; Goya Wannamethee; Peter Whincup; Amy Mulick Cassidy; Tom Gaunt; Ian Day; Stela McLachlan; Jacqueline Price; Meena Kumari; Mika Kivimaki; Eric Brunner; Claudia Langenberg; Yoav Ben-Shlomo; Aroon Hingorani; John Whittaker; Juan Pablo Casas; Frank Dudbridge
Journal:  Sci Rep       Date:  2016-06-24       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.